MX2021011548A - Proceso novedoso para la preparacion de filgotinib e intermediarios del mismo. - Google Patents

Proceso novedoso para la preparacion de filgotinib e intermediarios del mismo.

Info

Publication number
MX2021011548A
MX2021011548A MX2021011548A MX2021011548A MX2021011548A MX 2021011548 A MX2021011548 A MX 2021011548A MX 2021011548 A MX2021011548 A MX 2021011548A MX 2021011548 A MX2021011548 A MX 2021011548A MX 2021011548 A MX2021011548 A MX 2021011548A
Authority
MX
Mexico
Prior art keywords
filgotinib
intermediates
preparation
novel process
avoid
Prior art date
Application number
MX2021011548A
Other languages
English (en)
Inventor
Arijit Das
Sathe Dhananjay G
Bhavesh Patel
Eknath Kshirsagar
Dipak Patil
Ashok Matale
Original Assignee
Unichem Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unichem Lab Ltd filed Critical Unichem Lab Ltd
Publication of MX2021011548A publication Critical patent/MX2021011548A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a un proceso novedoso para la preparación de filgotinib o una sal farmacéuticamente aceptable o intermediarios del mismo, los cuales evitan la reacción de acoplamiento Suzuki. (ver Fórmula).
MX2021011548A 2019-03-30 2020-03-28 Proceso novedoso para la preparacion de filgotinib e intermediarios del mismo. MX2021011548A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201921012919 2019-03-30
PCT/IB2020/052977 WO2020201975A2 (en) 2019-03-30 2020-03-28 Novel process for the preparation of filgotinib and intermediates thereof

Publications (1)

Publication Number Publication Date
MX2021011548A true MX2021011548A (es) 2021-10-22

Family

ID=72666162

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011548A MX2021011548A (es) 2019-03-30 2020-03-28 Proceso novedoso para la preparacion de filgotinib e intermediarios del mismo.

Country Status (10)

Country Link
US (1) US20220185810A1 (es)
EP (1) EP3947381A2 (es)
JP (1) JP2022527512A (es)
CN (1) CN113677676A (es)
AU (1) AU2020251400A1 (es)
BR (1) BR112021019087A2 (es)
EA (1) EA202192389A1 (es)
MX (1) MX2021011548A (es)
WO (1) WO2020201975A2 (es)
ZA (1) ZA202107053B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110204542B (zh) * 2019-05-23 2022-05-20 四川伊诺达博医药科技有限公司 一种JAK1抑制剂Filgotinib的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719803D0 (en) * 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
TWI462920B (zh) * 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
CN104379173A (zh) * 2012-06-22 2015-02-25 加拉帕戈斯股份有限公司 用于治疗炎症的氨基三唑并吡啶及其药物组合物
AU2016257892A1 (en) * 2015-05-05 2017-11-09 Concert Pharmaceuticals, Inc. Deuterated filgotinib

Also Published As

Publication number Publication date
AU2020251400A1 (en) 2021-10-07
BR112021019087A2 (pt) 2021-11-30
US20220185810A1 (en) 2022-06-16
JP2022527512A (ja) 2022-06-02
CN113677676A (zh) 2021-11-19
ZA202107053B (en) 2022-11-30
WO2020201975A2 (en) 2020-10-08
WO2020201975A3 (en) 2020-12-03
EA202192389A1 (ru) 2022-01-21
EP3947381A2 (en) 2022-02-09

Similar Documents

Publication Publication Date Title
MX2019012942A (es) Compuestos de imidazo-piperidina fusionada como inhibidores de jak.
MX2021008002A (es) Sales nuevas y forma polimorfica del acido bempedoico.
PH12021550388A1 (en) Process for preparing jak inhibitors and intermediates thereof
NZ730730A (en) Novel carboxylic acid compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
MX2021004582A (es) Compuesto 2-azabiciclo hexano inhibidor de jak.
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
ZA202201503B (en) Urea compound for antagonizing lpa1 receptor
MX2011011776A (es) Nuevos profarmacos de triptolite.
MX2021003070A (es) Un proceso de fabricación de compuestos heterocíclicos de 2-nitroimino.
NZ774126A (en) Spd-1 variant - fc fusion proteins
MX2021011548A (es) Proceso novedoso para la preparacion de filgotinib e intermediarios del mismo.
MX2022007108A (es) Fabricacion de do3a protegido.
MX2020007091A (es) Proceso para la preparacion de crisaborola y sus intermediarios.
SG11201803867TA (en) Sodium channel blocker
MX2021004996A (es) Preparacion de 4-metiltetrahidropiranos 2-sustituidos a partir de 4-hidroxi-4-metiltetrahidropiranos 2-sustituidos como materiales de partida.
EP3762356A4 (en) IMPROVED PROCESS FOR MANUFACTURING INTERMEDIATE PRODUCTS
MX2021008323A (es) Preparacion de 5-aril pentanoles.
MX2021006692A (es) Proceso mejorado para preparar ozanimod.
WO2016079757A3 (en) NOVEL PROCESSES FOR THE PREPARATION OF SUBSTITUTED 5-HYDROXYMETHYL-OXAZOLIDINE-2-ONE
MX2022001549A (es) Nuevas sintesis telescopicas de 2-metoximetil-p-fenilendiamina.
WO2015104602A3 (en) A process for the preparation of anagliptin and its intermediates thereof
MX2020010343A (es) Proceso para la purificacion de biocomposiciones complejas.
MX2021009261A (es) Compuesto de fluorovinilbenzamida como inmunomodulador pd-l1.
MX2021001530A (es) Metodo de produccion de esteres carbonicos.
MX2020012065A (es) Compuestos de ciclopentano.